References
- 1. Piekutowska-Abramczuk D, Pronicka E, Krajewska-Walasek M. Rola genu SURF1 w patogenezie zespołu Leigha sprzężonego z deficytem aktywności oksydazy cytochromu C. Pediatria Polska 2008;83(3):212-217.
- 2. Tuppen HA, Hogan VE, He L. The p.M292T NDUFS2 mutation causes complex I-deficient Leigh syndrome in multiple families. Brain. 2010;133(10):2952-2963.
- 3. Piekutowska-Abramczuk D. The molecular background of Leigh syndrome. Neurol Neurochir. Pol. 2008;42(3):238-250.
- 4. Friedman SD, Shaw DW, Ishak G, et al. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev Disabil Res Rev. 2010;16(2):129-135.10.1002/ddrr.103
- 5. Baertling F, Rodenburg RJ, Schaper J, et al. A guide to diagnosis and treatment of Leigh syndrome. Neurol. Neurosurg Psychiatry, 2014;85(3): 257-265
- 6. Lake NJ, Bird MJ, Isohanni P, Paetau A. Leigh syndrome: neuropathology and pathogenesis. J Neuropathol.Exp. Neurol. 2015;74:482–492
- 7. Gerards M, Sallevelt SC, Smeets HJ. Leigh syndrome: Resolving the clinical and genetic heterogeneity paves the way for treatment options. Mol Genet Metab. 2016;117(3):300-312.